tirzepatide update today Tirzepatide, FDA, and Compounding: Understanding the Current Landscape Are Compounded Tirzepatide Safe? 2026

These findings are based on the results of two recently published clinical trials

It is not totally clear how else these drugs might improve chronic kidney disease, but one potential factor is that they might reduce inflammation, which can be harmfully high in people with the condition

Especially in older populations, we need to continue to gather more evidence. Older people, in particular, are at greater risk for health problems at lower body weights, he adds

Furthermore, the depletion of phosphatidylcholine exacerbates the activation of mast cells, which are key players in the immune system's inflammatory response

Its typically only prescribed on a short-term basis

While off-label use of GLP-1 drugs for weight loss is not widely covered by insurance at this point, future developments in this area are likely to have a profound impact on adoption rates